Literature DB >> 10396495

Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.

M Paunio1, H Peltola, M Valle, I Davidkin, M Virtanen, O P Heinonen.   

Abstract

OBJECTIVE: To study measles risk after revaccination.
DESIGN: A population-based case-control study during an epidemic season. MAIN OUTCOME MEASURE: Relative serologically confirmed measles risk. PARTICIPANTS AND METHODS: 153 vaccinated cases, mostly from rural areas, were serologically confirmed as measles at the central laboratory in 1988-89. A randomly selected group of 453 controls from either municipalities of vaccinated cases or from areas where measles attack rate was > 600/10(5), was identified via the population registry. Vaccination and measles histories of cases and controls were determined from official vaccination cards.
RESULTS: Once and twice vaccinated had crude relative risk 15.6 and 2.3 compared with thrice vaccinated. When cases who had received their first vaccination at less than 14 months of age were omitted from analysis, once vaccinated had 4.0 (95% CI 1.2, 16.6) times higher age adjusted measles risk compared with twice vaccinated. When, omission was extended to cases from one particular municipality where even revaccinees had high measles risk during an explosive outbreak the corresponding risk ratio was 17.8 (2.8, 67.8).
CONCLUSIONS: Twice vaccinated have better protection against epidemic measles compared with single dose recipients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10396495      PMCID: PMC1756841          DOI: 10.1136/jech.53.3.173

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  57 in total

1.  Vaccinated children get milder measles infection: a community study from Guinea-Bissau.

Authors:  P Aaby; J Bukh; J Leerhøy; I M Lisse; C H Mordhorst; I R Pedersen
Journal:  J Infect Dis       Date:  1986-11       Impact factor: 5.226

2.  Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland.

Authors:  H Peltola; V Karanko; T Kurki; V Hukkanen; M Virtanen; K Penttinen; M Nissinen; O P Heinonen
Journal:  Lancet       Date:  1986-01-18       Impact factor: 79.321

Review 3.  Measles and rubella in the United States.

Authors:  H W Hethcote
Journal:  Am J Epidemiol       Date:  1983-01       Impact factor: 4.897

4.  Risk factors for measles vaccine failure among immunized students.

Authors:  H F Hull; J M Montes; P C Hays; R L Lucero
Journal:  Pediatrics       Date:  1985-10       Impact factor: 7.124

5.  Measles and measles vaccine efficacy in a remote island population.

Authors:  R C McIntyre; S R Preblud; A Polloi; M Korean
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

6.  Epidemic measles and rubella in air force recruits: impact of immunization.

Authors:  G E Crawford; D H Gremillion
Journal:  J Infect Dis       Date:  1981-11       Impact factor: 5.226

7.  No measles in Finland.

Authors:  H Peltola; I Davidkin; M Valle; M Paunio; T Hovi; O P Heinonen; P Leinikki
Journal:  Lancet       Date:  1997-11-08       Impact factor: 79.321

8.  Continuing measles transmission in students despite school-based outbreak control program.

Authors:  S G Wassilak; W A Orenstein; P L Strickland; C A Butler; K J Bart
Journal:  Am J Epidemiol       Date:  1985-08       Impact factor: 4.897

9.  Further-attenuated measles vaccine: characteristics and use.

Authors:  S Krugman
Journal:  Rev Infect Dis       Date:  1983 May-Jun

10.  Antibody response following measles-mumps-rubella vaccine under conditions of customary use.

Authors:  P A Brunell; K Weigle; M D Murphy; Z Shehab; E Cobb
Journal:  JAMA       Date:  1983-09-16       Impact factor: 56.272

View more
  8 in total

1.  Immunity to measles in the Croatian population.

Authors:  Berislav Borcić; Renata Mazuran; Bernard Kaić
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  Immune response to 1 and 2 dose regimens of measles vaccine in Pakistani children.

Authors:  Hamidah Hussain; Dure Samin Akram; Subhash Chandir; Aamir J Khan; Ashraf Memon; Neal A Halsey
Journal:  Hum Vaccin Immunother       Date:  2013-08-08       Impact factor: 3.452

Review 3.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

4.  Human leukocyte antigen and interleukin 2, 10 and 12p40 cytokine responses to measles: is there evidence of the HLA effect?

Authors:  Inna G Ovsyannikova; Jenna E Ryan; Robert M Jacobson; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Cytokine       Date:  2007-01-17       Impact factor: 3.861

5.  Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children.

Authors:  Markus Ringler; Georg Göbel; Johannes Möst; Kurt Weithaler
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

6.  Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic.

Authors:  Cláudio S Pannuti; Ricardo José Morello; José Cássio de Moraes; Suely Pires Curti; Ana Maria S Afonso; Maria Cláudia Corrêa Camargo; Vanda A U F de Souza
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

7.  Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis.

Authors:  Sara Carazo; Marie-Noëlle Billard; Amélie Boutin; Gaston De Serres
Journal:  BMC Infect Dis       Date:  2020-03-29       Impact factor: 3.090

Review 8.  A guide to vaccinology: from basic principles to new developments.

Authors:  Andrew J Pollard; Else M Bijker
Journal:  Nat Rev Immunol       Date:  2020-12-22       Impact factor: 108.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.